- Price is above the Trend Line, keeping the weekly tape constructive.
- Activity pressure is positive on the latest completed week.
- Volume is elevated versus the 13-week average, confirming attention.
- Latest weekly return ranks in the strongest part of its sector group.
STRAP
CPH
Week ended 07 Aug 2026
Weekly Investor Report
Strategic Partners A/S · Healthcare · Biotechnology
Latest close
730.0 DKK
5.8%
latest week
Weekly setup
Mixed setup
The weekly trend is not active. Price is 17.0% above the Trend Line and sits at 36.8% of its 52-week range. The latest completed week returned 5.8%, after a 37.7% four-week move. The latest news-sentiment score is 50/100.
Setup score
48
out of 100
Latest Close
730.0 DKK
7 Aug 2026
1W Return
5.8%
latest completed week
4W Return
37.7%
short-term follow-through
12W Return
17.7%
quarterly tape
Trend Breadth
7.7%
4 of 52 weeks active
Volume Ratio
1.7x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Next-week expectancy is negative at 37.52% based on similar historical setup states.
- Activity pressure is weak, so confirmation is not yet broad enough.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
5.8%
Latest completed week; four-week move 37.7%.
Indicator stack
4/100
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Recent
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 37.52%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
50/100
0 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is 17.0% above the Trend Line and sits at 36.8% of its 52-week range. The latest completed week returned 5.8%, after a 37.7% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 1.7x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.2412-week average 0.23
12-week confirmation
Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure9/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.24Current proprietary activity-pressure read.
Buy signals1Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 37.7% over four weeks, 17.7% over 12 weeks, and -33.0% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year4
Trend breadth7.7%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure1.35Latest activity-pressure read.
Pressure change630.9%Four-week change in activity pressure.
Leadership-4.19Latest relative-leadership reading.
RS change88.0%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment50/100
Weighted news tone is neutral across 0 relevant articles.
0 positive · 0 neutral · 0 negativePatient CapitalRecent
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
Recent buy signal in the last 8 weeks
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-33.6%Distance below the 52-week high.
13-week volatility7.2%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher12 of 267 weeks finished lower.
Best week+20.8%Week of 17 Jul.
Worst week-10.8%Week of 27 Mar.
Latest week+5.8%Week of 7 Aug.
Shape of recent returns
Strong gains8
Modest gains4
Flat weeks7
Modest losses2
Sharp losses5
Recent vol7.2%13-week weekly-return volatility.
Base vol6.3%52-week weekly-return volatility.
Up/down split20/23Count of positive and negative weeks in the 52-week window.
Average skew5.3% / -5.9%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorDK Healthcare
4-week rank1 / 21
Group average4.0%
Trend breadth28.6%
Trend28.6%active weekly trend signals
MD66.7%positive activity pressure
RS14.3%positive relative leadership
Four-week leaders
IndustryDK Biotechnology
4-week rank1 / 7
Group average9.6%
Trend breadth0.0%
Trend0.0%active weekly trend signals
MD71.4%positive activity pressure
RS14.3%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape39/100
Trend, activity pressure, participation, and risk combine to a 39/100 tape read.
Indicator analysis28/100Latest 12-week confirmation: trend 0/12, activity pressure 9/12, relative leadership 0/12.
Activity pressure 0.24; No reversal markers Next-Week ExpectancyNegative 37.52%Next-week expectancy is negative with a 37.52% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100No published factor snapshot is available yet.
Patient CapitalRecentActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
Recent buy signal in the last 8 weeks Sentiment50/100Weighted news tone is neutral across 0 relevant articles.
Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 730.0 DKK | 5.8% | 624.0 DKK | 908.7 DKK | 1.35 | -4.19 | 135 | Off |
| 31 Jul 2026 | 690.0 DKK | 0.0% | 624.3 DKK | 911.9 DKK | 0.85 | -10.27 | 197 | Off |
| 24 Jul 2026 | 690.0 DKK | 7.8% | 625.9 DKK | 915.6 DKK | 0.56 | -11.05 | 178 | Off |
| 17 Jul 2026 | 640.0 DKK | 20.8% | 625.8 DKK | 919.7 DKK | 0.13 | -21.51 | 276 | Off |
| 10 Jul 2026 | 530.0 DKK | -10.2% | 626.9 DKK | 924.5 DKK | -0.25 | -34.97 | 53 | Off |
| 3 Jul 2026 | 590.0 DKK | 0.0% | 634.1 DKK | 930.7 DKK | -0.02 | -29.53 | 0 | Off |
| 26 Jun 2026 | 590.0 DKK | 1.7% | 638.8 DKK | 937.5 DKK | -0.12 | -26.75 | 0 | Off |
| 19 Jun 2026 | 580.0 DKK | 0.0% | 643.2 DKK | 944.4 DKK | 0.02 | -26.46 | 4 | Off |
| 12 Jun 2026 | 580.0 DKK | 0.0% | 650.5 DKK | 952.2 DKK | 0.36 | -28.29 | 38 | Off |
| 5 Jun 2026 | 580.0 DKK | -2.5% | 658.9 DKK | 959.7 DKK | 0.51 | -28.35 | 15 | Off |
| 29 May 2026 | 595.0 DKK | 0.8% | 667.7 DKK | 967.5 DKK | 0.72 | -28.37 | 2 | Off |
| 22 May 2026 | 590.0 DKK | -4.8% | 679.3 DKK | 982.3 DKK | 0.80 | -29.68 | 99 | Off |
| 15 May 2026 | 620.0 DKK | -4.6% | 688.0 DKK | 993.0 DKK | 0.74 | -26.20 | 53 | Off |
| 8 May 2026 | 650.0 DKK | 0.0% | 696.1 DKK | 996.7 DKK | 0.61 | -22.38 | 0 | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.